C.Uyemura & Co Ltd

C.Uyemura & Co Ltd maintains a strong liquidity position, with a current ratio of 4.7 and cash and equivalents amounting to ¥52.15 billion, which significantly exceeds its total liabilities of ¥24.47 billion. The company's price-to-book ratio is 3.73, and its debt-to-equity ratio is 0.01, indicating a conservative capital structure with minimal leverage. The company's profitability is robust, with a return on equity (ROE) of 13.27% and a return on assets (ROA) of 10.78%. These figures are well above the typical thresholds for the Commodity Chemicals industry, suggesting that C.Uyemura is efficiently utilizing its equity and assets to generate returns. C.Uyemura's revenue is concentrated in the chemical manufacturing segment, with no disclosed geographic diversification in the provided data. The company's primary revenue source is the sale of commodity chemicals, and there is no indication of significant diversification into other product lines or markets. The company's revenue for the latest period was ¥83.85 billion, and while no specific growth rate is provided, the operating cash flow of ¥19.20 billion and free cash flow of ¥10.92 billion suggest a stable and cash-generative business model. Analysts have provided a mean price target of ¥24,300, with a median of ¥24,300, indicating a generally neutral to slightly positive outlook. C.Uyemura & Co Ltd is currently assessed as having low liquidity and dilution risk. The company has no immediate filing-based liquidity or dilution flags, and its capital structure remains stable with minimal long-term debt. The absence of dilution risk is further supported by the fact that the number of shares outstanding has not changed between basic and diluted shares. There are no recent events or filings disclosed in the provided data that would indicate significant changes in the company's operations or financial position. The company's financials remain consistent with its historical performance, and there are no signs of material risk or volatility in the near term.